Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    P1.10 - Poster Session 1 - Chemotherapy

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 57
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.10-021 - Phase II study of S-1 plus irinotecan for EGFR-mutated non-small cell lung cancer (NSCLC) resistant to both platinum-based chemotherapy and EGFR-TKI: NJLCG0804

      09:30 - 09:30  |  Author(s): A. Inoue

      • Abstract

      Loading...

  • +

    P1.15 - Poster Session 1 - Thymoma

    • Type: Poster Session
    • Track: Thymoma & Other Thoracic Malignancies
    • Presentations: 9
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.15-003 - Phase II study of amrubicin (AMR) and carboplatin (CBDCA) for invasive thymoma (IT) and thymic carcinoma (TC) : North Japan Lung Cancer Group 0803

      09:30 - 09:30  |  Author(s): S. Kuyama

      • Abstract

      Loading...

  • +

    P3.11 - Poster Session 3 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 52
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.11-034 - One-year follow-up of a Phase I/II study of a highly selective ALK inhibitor CH5424802/RO5424802 in ALK-rearranged advanced non-small cell lung cancer (NSCLC)

      09:30 - 09:30  |  Author(s): A. Inoue

      • Abstract

      Loading...

  • +

    MO21 - Prognostic and Predictive Biomarkers V - EGFR

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 12
    • Moderators:D.C. Lam
    • Coordinates: 10/30/2013, 10:30 - 12:00, Bayside Auditorium A, Level 1
    • +

      MO21.03 - Variability of epidermal growth factor receptor (EGFR) mutations in serum during erlotinib therapy and its clinical implications: exploratory analysis of a phase II study of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC) harboring EGFR mutations

      10:40 - 10:45  |  Author(s): M. Maemondo

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.